China Pharma Holdings Return on Investment 2012-2026 | CPHI
Current and historical return on investment (ROI) values for China Pharma Holdings (CPHI) over the last 10 years.
| China Pharma Holdings ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2026-03-31 | $0.00B | $0.00B | -200.00% |
| 2025-12-31 | $0.00B | $0.00B | -100.00% |
| 2025-09-30 | $0.00B | $0.01B | -64.00% |
| 2025-06-30 | $0.00B | $0.01B | -48.48% |
| 2025-03-31 | $0.00B | $0.01B | -47.06% |
| 2024-12-31 | $0.00B | $0.01B | -44.44% |
| 2024-09-30 | $0.00B | $0.01B | -44.44% |
| 2024-06-30 | $0.00B | $0.01B | -44.44% |
| 2024-03-31 | $0.00B | $0.01B | -44.44% |
| 2023-12-31 | $0.00B | $0.00B | -47.06% |
| 2023-09-30 | $0.00B | $0.00B | -100.00% |
| 2023-06-30 | $0.00B | 0 | 0.00% |
| 2023-03-31 | $0.00B | $0.00B | -133.33% |
| 2022-12-31 | $0.00B | $0.01B | -84.21% |
| 2022-09-30 | $0.00B | $0.01B | -53.33% |
| 2022-06-30 | $0.00B | $0.01B | -53.33% |
| 2022-03-31 | $0.00B | $0.01B | -57.14% |
| 2021-12-31 | $0.00B | $0.01B | -61.54% |
| 2021-09-30 | $0.00B | $0.01B | -66.67% |
| 2021-06-30 | $0.00B | $0.01B | -48.48% |
| 2021-03-31 | $0.00B | $0.01B | -32.43% |
| 2020-12-31 | $0.00B | $0.01B | -30.77% |
| 2020-09-30 | $-0.02B | $0.01B | -204.88% |
| 2020-06-30 | $-0.02B | $0.02B | -137.70% |
| 2020-03-31 | $-0.02B | $0.02B | -106.02% |
| 2019-12-31 | $-0.02B | $0.03B | -77.78% |
| 2019-09-30 | $-0.01B | $0.03B | -30.30% |
| 2019-06-30 | $-0.01B | $0.04B | -30.34% |
| 2019-03-31 | $-0.01B | $0.04B | -27.50% |
| 2018-12-31 | $-0.01B | $0.04B | -24.86% |
| 2018-09-30 | $-0.02B | $0.05B | -35.42% |
| 2018-06-30 | $-0.02B | $0.05B | -31.78% |
| 2018-03-31 | $-0.02B | $0.06B | -31.03% |
| 2017-12-31 | $-0.02B | $0.06B | -30.77% |
| 2017-09-30 | $-0.01B | $0.07B | -12.08% |
| 2017-06-30 | $-0.01B | $0.07B | -11.64% |
| 2017-03-31 | $-0.01B | $0.07B | -11.19% |
| 2016-12-31 | $-0.01B | $0.08B | -10.63% |
| 2016-09-30 | $-0.02B | $0.08B | -25.32% |
| 2016-06-30 | $-0.02B | $0.08B | -18.07% |
| 2016-03-31 | $-0.01B | $0.09B | -13.30% |
| 2015-12-31 | $-0.02B | $0.10B | -15.83% |
| 2015-09-30 | $-0.02B | $0.10B | -22.00% |
| 2015-06-30 | $-0.03B | $0.11B | -28.44% |
| 2015-03-31 | $-0.04B | $0.12B | -35.34% |
| 2014-12-31 | $-0.04B | $0.13B | -30.83% |
| 2014-09-30 | $-0.03B | $0.14B | -18.28% |
| 2014-06-30 | $-0.02B | $0.14B | -15.44% |
| 2014-03-31 | $-0.02B | $0.11B | -16.51% |
| 2013-12-31 | $-0.02B | $0.07B | -25.85% |
| 2013-09-30 | $-0.01B | $0.04B | -32.21% |
| 2013-06-30 | $-0.01B | 0 | 0.00% |
| 2013-03-31 | $0.00B | 0 | 0.00% |
| 2012-12-31 | $0.01B | 0 | 0.00% |
| 2012-09-30 | $0.01B | 0 | 0.00% |
| 2012-06-30 | $0.02B | 0 | 0.00% |
| 2012-03-31 | $0.02B | 0 | 0.00% |
| 2011-12-31 | $0.02B | 0 | 0.00% |
| 2011-09-30 | $0.03B | 0 | 0.00% |
| 2011-06-30 | $0.03B | 0 | 0.00% |
| 2011-03-31 | $0.02B | 0 | 0.00% |
| 2010-12-31 | $0.02B | 0 | 0.00% |
| 2010-09-30 | $0.02B | 0 | 0.00% |
| 2010-06-30 | $0.02B | 0 | 0.00% |
| 2010-03-31 | $0.02B | 0 | 0.00% |
| 2009-12-31 | $0.02B | 0 | 0.00% |
| 2009-09-30 | $0.02B | 0 | 0.00% |
| 2009-06-30 | $0.02B | 0 | 0.00% |
| 2009-03-31 | $0.02B | 0 | 0.00% |
| 2008-12-31 | $0.02B | 0 | 0.00% |
| 2008-09-30 | $0.02B | 0 | 0.00% |
| 2008-06-30 | $0.02B | 0 | 0.00% |
| 2008-03-31 | $0.02B | 0 | 0.00% |
| 2007-12-31 | $0.01B | 0 | 0.00% |
| 2007-09-30 | $0.01B | 0 | 0.00% |
| 2007-06-30 | $0.01B | 0 | 0.00% |
| 2007-03-31 | $0.01B | 0 | 0.00% |
| 2006-12-31 | $0.01B | 0 | 0.00% |
| 2006-09-30 | $0.01B | 0 | 0.00% |
| 2006-06-30 | $0.01B | 0 | 0.00% |
| 2006-03-31 | $0.01B | 0 | 0.00% |
| 2005-12-31 | $0.00B | 0 | 0.00% |
| 2005-06-30 | $0.00B | 0 | 0.00% |
| 2003-09-30 | $0.00B | $0.00B | 0.00% |
| 2002-12-31 | $0.00B | -0 | 0.00% |
| 2002-09-30 | $0.00B | 0 | 0.00% |
| 2002-03-31 | $0.00B | 0 | 0.00% |
| 2001-12-31 | $0.00B | 0 | 0.00% |
| 2001-09-30 | $0.00B | 0 | 0.00% |
| 2001-06-30 | $0.00B | 0 | 0.00% |
| 2001-03-31 | $0.00B | 0 | 0.00% |
| 2000-12-31 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.026B | $0.004B |
| CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |